Exact Mass: 303.1682

Exact Mass Matches: 303.1682

Found 87 metabolites which its exact mass value is equals to given mass value 303.1682, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

SCHEMBL4290912

N(6)-[(indol-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1583)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol

alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol

C21H21NO (303.1623)


   

Valyltryptophan

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3 (303.1583)


Valyltryptophan is a dipeptide composed of valine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   

Tryptophyl-Valine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}-3-methylbutanoate

C16H21N3O3 (303.1583)


Tryptophyl-Valine is a dipeptide composed of tryptophan and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Pimelylcarnitine

(3R)-3-[(6-carboxyhexanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


Pimelylcarnitine is an acylcarnitine. More specifically, it is an pimelic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Pimelylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine pimelylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2,2-dimethylpentanedioylcarnitine

3-[(4-carboxy-4,4-dimethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


2,2-dimethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2,2-dimethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2,2-dimethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2,2-dimethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Ethylpentanedioylcarnitine

3-[(4-carboxy-4-ethylbutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


2-Ethylpentanedioylcarnitine is an acylcarnitine. More specifically, it is an 2-ethylpentanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylpentanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Ethylpentanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

O-Pimeloylcarnitine

4-[(6-Carboxyhexanoyl)oxy]-4-(trimethylammonio)butanoic acid

C14H25NO6 (303.1682)


   

Aditoprim

5-{[4-(dimethylamino)-3,5-dimethoxyphenyl]methyl}pyrimidine-2,4-diamine

C15H21N5O2 (303.1695)


   

Aptiganel

N-(3-ethylphenyl)-N-methyl-N-(naphthalen-1-yl)guanidine

C20H21N3 (303.1735)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

Zolmitriptan N-Oxide

N,N-dimethyl-2-{5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl}ethanamine oxide

C16H21N3O3 (303.1583)


   

dehydronitramidine

dehydronitramidine

C20H21N3 (303.1735)


   

Schoberidine

Schoberidine

C20H21N3 (303.1735)


   

(+)-mostueine|Mostueine.|mostuenine

(+)-mostueine|Mostueine.|mostuenine

C20H21N3 (303.1735)


   

(E)-N-methyl-N-(1-naphthylmethyl)-3-(4-hydroxyphenyl)-2-propen-1-amine

(E)-N-methyl-N-(1-naphthylmethyl)-3-(4-hydroxyphenyl)-2-propen-1-amine

C21H21NO (303.1623)


   

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +

C20H21N3 (303.1735)


   

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

2-[(3-isopropoy-O-beta-D-glucopyranosyl)oxy]-2-methylbutanenitrile

C14H25NO6 (303.1682)


   
   

(E)-N-methyl-N-(1-naphthylmethyl)-3-(3-hydroxyphenyl)-2-propen-1-amine

(E)-N-methyl-N-(1-naphthylmethyl)-3-(3-hydroxyphenyl)-2-propen-1-amine

C21H21NO (303.1623)


   

Tribenzylamine N-oxide

Tribenzylamine N-oxide

C21H21NO (303.1623)


   

Antibiotic TAN 1169A

Antibiotic TAN 1169A

C16H21N3O3 (303.1583)


   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

[C11H23N6O4]+ (303.1781)


   

Val Trp

Dipeptide-2

C16H21N3O3 (303.1583)


Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   
   

TRP-Val

2-(2-amino-3-methylbutanamido)-3-(1H-indol-3-yl)propanoic acid

C16H21N3O3 (303.1583)


A dipeptide formed from L-tryptophan and L-valine residues.

   

Val-TRP

2-[2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C16H21N3O3 (303.1583)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor Dipeptide 2 (N-Valyltryptophan; Val-Trp) is a bioactive peptide with anti-aging effect and has been reported used as a cosmetic ingredient[1].

   

(2E)-N-(2,4-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

(2E)-N-(2,4-DIMETHYLPHENYL)-2-(HYDROXYIMINO)ACETAMIDE

C21H21NO (303.1623)


   

(R)-2-AMINO-1,1,3-TRIPHENYLPROPAN-1-OL

(R)-2-AMINO-1,1,3-TRIPHENYLPROPAN-1-OL

C21H21NO (303.1623)


   

Boc-D-Glu(OtBu)-OH

Boc-D-Glu(OtBu)-OH

C14H25NO6 (303.1682)


   

3-azido-2 3-dideoxy-1-o-(t-butyldimethy&

3-azido-2 3-dideoxy-1-o-(t-butyldimethy&

C12H25N3O4Si (303.1614)


   

2,4-bis[(4-aminophenyl)methyl]aniline

2,4-bis[(4-aminophenyl)methyl]aniline

C20H21N3 (303.1735)


   

N,N-Dibenzyl-p-anisidine

N,N-Dibenzyl-p-anisidine

C21H21NO (303.1623)


   

Boc-Glu(OtBu)-OH

Boc-Glu(OtBu)-OH

C14H25NO6 (303.1682)


   
   

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

2-((4-Phenylpiperazine-1-yl)methyl)quinoline

C20H21N3 (303.1735)


   

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

tert-Butyl 4-(5H-pyrrolo[3,2-d]pyrimidin-4-yl)piperazine-1-carboxylate

C15H21N5O2 (303.1695)


   

Butoxamine hydrochloride

Butoxamine hydrochloride

C15H26ClNO3 (303.1601)


Butaxamine (Butoxamin) hydrochloride is a specific β2-adrenergic receptor blocker. Butaxamine hydrochloride inhibits the decreases in urine volume in ethanol-anesthetized, water-diuretic rats[1].

   

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

(bis-tert-butoxycarbonylmethyl-amino)-acetic acid

C14H25NO6 (303.1682)


   

(2S)-2-Amino-1,1,3-triphenyl-1-propanol

(2S)-2-Amino-1,1,3-triphenyl-1-propanol

C21H21NO (303.1623)


   

BENZYL-(4-BENZYLOXYBENZYL)AMINE

BENZYL-(4-BENZYLOXYBENZYL)AMINE

C21H21NO (303.1623)


   

7-((1-METHYLPIPERIDIN-4-YL)METHOXY)-6-METHOXYQUINAZOLIN-4(3H)-ONE

7-((1-METHYLPIPERIDIN-4-YL)METHOXY)-6-METHOXYQUINAZOLIN-4(3H)-ONE

C16H21N3O3 (303.1583)


   

Benzyl 4-(2-oxoimidazolidin-1-yl)piperidine-1-carboxylate

Benzyl 4-(2-oxoimidazolidin-1-yl)piperidine-1-carboxylate

C16H21N3O3 (303.1583)


   

Boc-d-glu-otbu

Boc-d-glu-otbu

C14H25NO6 (303.1682)


   

tert-butyl 4-(1,3-benzoxazol-2-yl)piperazine-1-carboxylate

tert-butyl 4-(1,3-benzoxazol-2-yl)piperazine-1-carboxylate

C16H21N3O3 (303.1583)


   

(1S,2R)-n-benzyl-2-amino-1,2-diphenylethanol

(1S,2R)-n-benzyl-2-amino-1,2-diphenylethanol

C21H21NO (303.1623)


   

4-[1-Methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]butanoic acid

4-[1-Methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]butanoic acid

C16H21N3O3 (303.1583)


   

Aditoprim

Aditoprime

C15H21N5O2 (303.1695)


C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists C254 - Anti-Infective Agent > C52588 - Antibacterial Agent

   

5-tert-Butyl-4-diethylaminomethyl-2-methyl-furan-3-carboxylic acid hydrochloride

5-tert-Butyl-4-diethylaminomethyl-2-methyl-furan-3-carboxylic acid hydrochloride

C15H26ClNO3 (303.1601)


   

N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine Oxide

N,N-dimethyl-2-[5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indol-3-yl]ethanamine Oxide

C16H21N3O3 (303.1583)


   

(1-Tert-butyl-5-phenyl-1h-pyrrol-3-yl)(phenyl)methanone

(1-Tert-butyl-5-phenyl-1h-pyrrol-3-yl)(phenyl)methanone

C21H21NO (303.1623)


   

(3Z,5Z)-3,5-bis[(4-methylphenyl)methylidene]piperidin-4-one

(3Z,5Z)-3,5-bis[(4-methylphenyl)methylidene]piperidin-4-one

C21H21NO (303.1623)


   

N6-[(Indole-3-yl)acetyl]-L-lysine

N6-[(Indole-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1583)


   
   

Pimelylcarnitine

Pimelylcarnitine

C14H25NO6 (303.1682)


   

2-Ethylpentanedioylcarnitine

2-Ethylpentanedioylcarnitine

C14H25NO6 (303.1682)


   

2,2-dimethylpentanedioylcarnitine

2,2-dimethylpentanedioylcarnitine

C14H25NO6 (303.1682)


   

3-Methyladipoylcarnitine

3-Methyladipoylcarnitine

C14H25NO6 (303.1682)


   

5-(3-Methylbutyl)-5-(2-pyridin-4-ylethyl)-1,3-diazinane-2,4,6-trione

5-(3-Methylbutyl)-5-(2-pyridin-4-ylethyl)-1,3-diazinane-2,4,6-trione

C16H21N3O3 (303.1583)


   

O-pimelylcarnitine

O-pimelylcarnitine

C14H25NO6 (303.1682)


An O-acylcarnitine in which the acyl group specified is pimelyl.

   

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

3-(1-methyl-2-oxoimidazo[4,5-b]pyridin-3-yl)-N-propan-2-ylpyrrolidine-1-carboxamide

C15H21N5O2 (303.1695)


   

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

(4S)-4-(6-carboxyhexanoyloxy)-4-(trimethylazaniumyl)butanoate

C14H25NO6 (303.1682)


   

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3R,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2R,3S,6S)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

[(2S,3S,6R)-3-amino-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-2-oxanyl]methanol

C15H21N5O2 (303.1695)


   

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

2-amino-3-methyl-4H-imidazol-5-one;2-(6-methoxy-1H-indol-3-yl)ethanamine

C15H21N5O2 (303.1695)


   

tetra(methoxymethyl)melamine (putative)

tetra(methoxymethyl)melamine (putative)

C11H23N6O4+ (303.1781)


   

2-(2-Hydroxyethoxy)-N-(2-(dimethylamino)ethyl)-4-qutnolinecarboxamide

2-(2-Hydroxyethoxy)-N-(2-(dimethylamino)ethyl)-4-qutnolinecarboxamide

C16H21N3O3 (303.1583)


   

N(6)-[(indol-3-yl)acetyl]-L-lysine

N(6)-[(indol-3-yl)acetyl]-L-lysine

C16H21N3O3 (303.1583)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

Aptiganel

Aptiganel

C20H21N3 (303.1735)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents

   

O-pimelyl-L-carnitine

O-pimelyl-L-carnitine

C14H25NO6 (303.1682)


An O-acyl-L-carnitine that is L-carnitine having a pimelyl group as the acyl substituent.

   

O-Pimeloylcarnitine

O-Pimeloylcarnitine

C14H25NO6 (303.1682)


An O-acylcarnitine having pimeloyl as the acyl substituent.

   

N(6)-[(indol-3-yl)acetyl]-L-lysine zwitterion

N(6)-[(indol-3-yl)acetyl]-L-lysine zwitterion

C16H21N3O3 (303.1583)


Zwitterionic form of N(6)-[(indol-3-yl)acetyl]-L-lysine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.

   
   

N(6)-[(Indol-3-yl)acetyl]-lysine

N(6)-[(Indol-3-yl)acetyl]-lysine

C16H21N3O3 (303.1583)


   
   

n-{3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}guanidine

n-{3-[(2s,5s)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}guanidine

C15H21N5O2 (303.1695)


   

17-ethyl-3-methyl-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13(18),14,16-heptaene

17-ethyl-3-methyl-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13(18),14,16-heptaene

C20H21N3 (303.1735)


   

(2s)-2-amino-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}hexanoic acid

(2s)-2-amino-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}hexanoic acid

C16H21N3O3 (303.1583)


   

(2s)-2-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

(2s)-2-{[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

C14H25NO6 (303.1682)


   

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene

C20H21N3 (303.1735)


   

2-{[3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

2-{[3,5-dihydroxy-6-(hydroxymethyl)-4-isopropoxyoxan-2-yl]oxy}-2-methylbutanenitrile

C14H25NO6 (303.1682)


   

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

C20H21N3 (303.1735)


   

2-amino-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}hexanoic acid

2-amino-6-{[1-hydroxy-2-(1h-indol-3-yl)ethylidene]amino}hexanoic acid

C16H21N3O3 (303.1583)


   

(1r,15r,16s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

(1r,15r,16s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene

C20H21N3 (303.1735)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-3-methylbutylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C16H21N3O3 (303.1583)